1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Autologous genetically engineered NY-ESO-1(c259)T in HLA-A*02:01, HLA*02:05 and HLA*02:06 positive patients with NY-ESO-1 expressing tumors
    Meeting Abstract

    Mackall, C.; D'Angelo, S. P.; Grupp, S. A.; Odunsi, K.; Cristea, M. C.; Linette, G. P.; Kluger, H. M.; Kari, G.; Pandite, L.; Holdich, T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genetic plasma cell signatures in high-risk smoldering myeloma versus multiple myeloma patients
    Meeting Abstract

    Mailankody, S.; Korde, N.; Roschewski, M. J.; Christofferson, A.; Boateng, M.; Zhang, Y.; Manasanch, E. E.; Kazandjian, D. G.; Kwok, M.; Bhutani, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in adults with acute myeloid leukemia (AML) in first complete remission (CR)
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M. G.; Rosenblat, T. L.; Jurcic, J. G.; Rampal, R.; Park, J. H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Determining barriers to effective data sharing in cancer genomic sequencing initiatives: A Global Alliance for Genomics and Health (GA4GH) survey
    Meeting Abstract

    Lewin, J. H.; Vis, D. J.; Voest, E. E.; Liao, R.; Nederlof, P. M.; Conley, B. A.; Solit, D. B.; Corless, C. L.; Campregher, P. V.; Tyrell, V.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Food and Drug Administration analysis of 1332 single patient and emergency use expanded access (compassionate use) requests for patients with cancer over a duration of three years (2012-2014)
    Meeting Abstract

    Lemery, S. J.; Mailankody, S.; Kazandjian, D.; Smit, M. A. D.; Blumenthal, G. M.; Kim, T.; Keegan, P.; Pazdur, R.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic Merkel cell carcinoma previously treated with chemotherapy: Results of the phase 2 JAVELIN Merkel 200 trial
    Meeting Abstract

    Kaufman, H.; Russell, J. S.; Hamid, O.; Bhatia, S.; Terheyden, P.; D'Angelo, S. P.; Shih, K. C.; Lebbe, C.; Linette, G. P.; Milella, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Retrospective review of subsequent treatments (tx) for esophagogastric adenocarcinomas (EGA) refractory to FOLFOX
    Meeting Abstract

    Kelly, C. M.; Janjigian, Y. Y.; Kelsen, D. P.; Capanu, M.; Chou, J. F.; Ilson, D. H.; Ku, G. Y.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Tuvy, Y.; Bouvier, N.; Riches, J. C.; Margolis, M.; Millang, B. M.; Scott, S. N.; Kundra, R.; Castel, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Outcomes of systemic therapy for patients with metastatic undifferentiated pleomorphic sarcoma (UPS)
    Meeting Abstract

    Adrianzen Herrera, D. A.; Kuk, D.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Chi, P.; Agaram, N. P.; Antonescu, C. R.; Hameed, M.; Tap, W. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Cerdulatinib (PRT062070): A dual SYK/JAK inhibitor in patients with relapsed/refractory b-cell malignancies - Pharmacokinetic and pharmacodynamic outcomes with twice-daily (BID) vs once-daily (QD) dosing
    Meeting Abstract

    Hamlin, P. A.; Flinn, I.; Wagner-Johnston, N.; Burger, J.; Michelson, G.; Pandey, A.; Birrell, M.; Coffey, G.; Leeds, J.; Sabalvaro-Torres, A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save